FormWeb • filgrastim

Ochsner Health

Ochsner Health System Formulary

Formulary Addition Request Questions or Suggestions?

Search by class Show Therapeutic Classes

SDS Online Do Not Crush OHS Pharmacy Contact Louisiana Poison Control
(800) 222-1222

Add Formweb to your mobile device

Android iOS

Ochsner Health COVID-19 SharePoint Site "Safety On Site" Click here to enter an S.O.S.

Medications listed are available on OH EPIC Formulary, unless otherwise noted.
Not all formulary medications are available at each facility. Please refer to your local pharmacy for available inventory.

Ochsner Health

Ochsner Health System Formulary

Formulary Addition Request Questions or Suggestions?

Search results for:

filgrastim

filgrastim

Drug Name	Form	Strength
Nivestym	SOLUTION, INJECTABLE	aafi 300 mcg; 480 mcg
Releuko (filgrastim-ayow)	SOLUTION, INJECTABLE	ayow 300 mcg; 480 mcg
Zarxio (filgrastim-sndz)	SOLUTION, INJECTABLE	sndz 300 mcg; 480 mcg
Neupogen	SOLUTION, INJECTABLE	300; 480 mcg

VIEW MORE Hematopoietic Agents
CLASS

Additional Information and Links

Restricted:

Inpatient formulary:
- Releuko is the OH-preferred filgrastim biosimilar for all indications for adults and pediatrics EXCEPT:
  - Stem cell mobilization prior to (bone marrow) stem cell transplant
  - Colony stimulation post stem cell (bone marrow) transplantation
  - Pediatrics patients < 36 kg or requiring intravenous growth factor administration

If a filgrastim biosimilar/tbo-filgrastim (Granix) is ordered for one of the above exceptions, please initiate therapeutic interchange to filgrastim (Neupogen) at the same ordered dose.

If filgrastim (Neupogen), tbo-filgrastim (Granix), or any other filgrastim biosimilar is ordered besides filgrastim-AYOW (Releuko) for an indication not on the above list, please initiate the therapeutic interchange to filgrastim-AYOW (Releuko) at the same ordered dose.

Outpatient formulary:

Releuko is the OH-preferred filgrastim biosimilar. However, it is also driven by payer preference.

Therapeutic Interchange:

Requested	Dispensed	Exceptions:
filgrastim (Neupogen)	filgrastim-AYOW (Releuko)	Stem cell mobilization prior to (bone marrow) stem cell transplant Colony stimulation post stem cell (bone marrow) transplantation Pediatrics patients < 36 kg or requiring intravenous growth factor administration

Last updated: Jul. 21, 2025

This site is intended for the staff of Ochsner Health. While others may view accessible pages, Ochsner Health makes no warranty, express or implied, as to the use of this information outside of Ochsner Health.